Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02659020
Title A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

sarcoma

Therapies

Olaratumab

Docetaxel + Gemcitabine

Age Groups:
Covered Countries USA


No variant requirements are available.